Inactive Total Small Business Set-Aside (FAR 19.5)

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, and issued pursuant of FAR 13.003(a), Simplified Acquisition Procedures found ... This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, and issued pursuant of FAR 13.003(a), Simplified Acquisition Procedures found in FAR Part 13 shall be used to the maximum extent practicable for the acquisition of supplies not exceeding the simplified acquisition threshold. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. Solicitation HT9408-23-Q-0010 is issued as a Request for Quote (RFQ). This solicitation incorporates provisions and clauses for commercial items in effect through Federal Acquisition Circular 2023-02. This acquisition will utilize full and open competition. The associated North American Industry Classification System (NAICS) code for this acquisition is 325412, Pharmaceutical Preparation Manufacturing; Standard Industrial Classification code is 6505, Drugs and Biologicals; Small Business size standard for this NAICS is 1,300 employees. Schedule of Supplies: Prefilled Syringes Ephedrine (5 mg/mL) in NS 10 mL (in 10 mL BD syringe), 576 Units, Yearly Ketamine (10 mg/mL) in NS 5 mL (in 10 mL BD syringe), 360 Units, Yearly Phenylephrine (100 mcg/mL) in NS 10 mL (in 10 mL BD syringe), 384 Units, Yearly Rocuronium (10 mg/mL) 5 mL (in 10 mL BD syringe), 480 Units, Yearly Succinylcholine (20 mg/mL) 5 mL (in 10 mL BD syringe), 480 Units, Yearly See Attachments for additional requirements.